These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 11442479)

  • 1. Determination of heparin-platelet factor 4-IgG antibodies improves diagnosis of heparin-induced thrombocytopenia.
    Lindhoff-Last E; Gerdsen F; Ackermann H; Bauersachs R
    Br J Haematol; 2001 Jun; 113(4):886-90. PubMed ID: 11442479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
    Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
    Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia.
    Legnani C; Cini M; Pili C; Boggian O; Frascaro M; Palareti G
    Thromb Haemost; 2010 Aug; 104(2):402-9. PubMed ID: 20539902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-PF4-heparin immunoglobulin G is the major class of heparin-induced thrombocytopenia antibody: findings of an enzyme-linked immunofiltration assay using membrane-bound hPF4-heparin.
    Vun CM; Evans S; Chesterman CN
    Br J Haematol; 2001 Jan; 112(1):69-75. PubMed ID: 11167786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of a new immunoassay for the diagnosis of heparin-induced thrombocytopenia and improved specificity when detecting IgG antibodies.
    Pouplard C; Leroux D; Regina S; Rollin J; Gruel Y
    Thromb Haemost; 2010 Jan; 103(1):145-50. PubMed ID: 20062918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, isotype, and functionality of antiheparin-platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia. The pathogenic role of IgG.
    Untch B; Ahmad S; Jeske WP; Messmore HL; Hoppensteadt DA; Walenga JM; Lietz H; Fareed J
    Thromb Res; 2002 Jan; 105(2):117-23. PubMed ID: 11958801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes.
    Greinacher A; Juhl D; Strobel U; Wessel A; Lubenow N; Selleng K; Eichler P; Warkentin TE
    J Thromb Haemost; 2007 Aug; 5(8):1666-73. PubMed ID: 17488345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and clinical relevance of anti-platelet factor 4/heparin antibodies before cardiac surgery.
    Selleng S; Malowsky B; Itterman T; Bagemühl J; Wessel A; Wollert HG; Warkentin TE; Greinacher A
    Am Heart J; 2010 Aug; 160(2):362-9. PubMed ID: 20691844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further characterization of antibody and antigen in heparin-induced thrombocytopenia.
    Newman PM; Chong BH
    Br J Haematol; 1999 Nov; 107(2):303-9. PubMed ID: 10583216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of the immune response in heparin-induced thrombocytopenia.
    Warkentin TE; Sheppard JA; Moore JC; Cook RJ; Kelton JG
    Blood; 2009 May; 113(20):4963-9. PubMed ID: 19144981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG classification of anti-PF4/heparin antibodies to identify patients with heparin-induced thrombocytopenia during mechanical circulatory support.
    Schenk S; El-Banayosy A; Morshuis M; Arusoglu L; Eichler P; Lubenow N; Tenderich G; Koerfer R; Greinacher A; Prohaska W
    J Thromb Haemost; 2007 Feb; 5(2):235-41. PubMed ID: 17083649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid and accurate Bayesian diagnosis of heparin-induced thrombocytopenia.
    Marchetti M; Barelli S; Zermatten MG; Monnin-Respen F; Matthey-Guirao E; Nicolas N; Gomez F; Goodyer M; Gerschheimer C; Alberio L
    Blood; 2020 Apr; 135(14):1171-1184. PubMed ID: 31945147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies.
    Vayne C; Guery EA; Kizlik-Masson C; Rollin J; Bauters A; Gruel Y; Pouplard C
    Br J Haematol; 2017 Dec; 179(5):811-819. PubMed ID: 29048130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-heparin/platelet factor 4 antibody optical density values and the confirmatory procedure in the diagnosis of heparin-induced thrombocytopenia.
    Whitlatch NL; Perry SL; Ortel TL
    Thromb Haemost; 2008 Oct; 100(4):678-84. PubMed ID: 18841292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of isolated heparin-induced thrombocytopenia and risk of thrombosis by IgG-specific anti-PF4/heparin ELISA.
    Radaideh SM; Frenkel EP; Dowell JE; Sarode R; Shen YM
    Clin Appl Thromb Hemost; 2012; 18(2):215-7. PubMed ID: 22067544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.
    Demma LJ; Winkler AM; Levy JH
    Anesth Analg; 2011 Oct; 113(4):697-702. PubMed ID: 21788317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the specificity of the PF4 ELISA in diagnosing heparin-induced thrombocytopenia.
    McFarland J; Lochowicz A; Aster R; Chappell B; Curtis B
    Am J Hematol; 2012 Aug; 87(8):776-81. PubMed ID: 22641378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of 4T score and heparin-platelet factor 4 antibody in the diagnosis of heparin-induced thrombocytopenia (HIT) in cancer.
    Wong M; Oo TH; Qiao W; Garg N; Rojas-Hernandez CM
    J Thromb Thrombolysis; 2017 Aug; 44(2):261-266. PubMed ID: 28677022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-heparin/platelet factor 4 antibodies and heparin-induced thrombocytopenia--review].
    Lei Q; Chen L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):457-60. PubMed ID: 18426686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis.
    Padmanabhan A; Jones CG; Curtis BR; Bougie DW; Sullivan MJ; Peswani N; McFarland JG; Eastwood D; Wang D; Aster RH
    Chest; 2016 Sep; 150(3):506-15. PubMed ID: 26905366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.